SearchDictionaryMobileLogin

Tonsillitis

1312  relevant articles (78 outcomes, 188 trials/studies) found for this Disease

Description: Inflammation of the tonsils, especially the PALATINE TONSILS but the ADENOIDS (pharyngeal tonsils) and lingual tonsils may also be involved. Tonsillitis usually is caused by bacterial infection. Tonsillitis may be acute, chronic, or recurrent.

Also Known As:
Tonsillitides

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pharyngitis (Sore Throat)
2. Pneumonia (Pneumonitis)
3. Respiratory Tract Infections (Respiratory Tract Infection)
4. Infection
5. Bronchitis

Experts

1. Brook, Itzhak: 3 articles (12/2007 - 01/2005)
2. Yamanaka, Noboru: 3 articles (05/2006 - 06/2003)
3. Brook, I: 3 articles (12/2001 - 06/2001)
4. Smith, Timothy L: 2 articles (01/2008 - 01/2008)
5. Stewart, Michael G: 2 articles (01/2008 - 01/2008)
6. Weaver, Edward M: 2 articles (01/2008 - 01/2008)
7. Witsell, David L: 2 articles (01/2008 - 01/2008)
8. Orvidas, Laura J: 2 articles (01/2008 - 01/2008)
9. Yueh, Bevan: 2 articles (01/2008 - 01/2008)
10. Goldstein, Nira A: 2 articles (01/2008 - 01/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Tonsillitis:
1. Penicillin V (Phenoxymethylpenicillin)FDA LinkGeneric
2. Anti-Bacterial Agents (Antibiotics)IBA
3. Penicillins (Penicillin)FDA Link
4. Amoxicillin (Wymox)FDA LinkGeneric
5. Erythromycin (Erycette)FDA LinkGeneric
6. Azithromycin (Zithromax)FDA LinkGeneric
7. Clarithromycin (Biaxin)FDA LinkGeneric
8. Cefaclor (Ceclor)FDA LinkGeneric
9. cefprozil (Cefzil)FDA LinkGeneric
10. telithromycin (Ketek)FDA Link
10/01/2003 - "RESULTS: Treatment with telithromycin for either 5 days (AECB, AMS and tonsillitis/pharyngitis) or 7-10 days (CAP and AMS) provided high rates of clinical and bacteriologic cure (5-day, 87.0% and 86.0%, respectively; 7 to 10-days, 90.3% and 90.5%, respectively) that were equivalent to those of a 10-day course of comparator antibacterials (86.5% and 86.5%, respectively). "
01/01/2001 - "In clinical trials in patients with community-acquired pneumonia (CAP), acute exacerbations of chronic bronchitis (AECB) or pharyngitis/tonsillitis caused by group A beta-haemolytic streptococci, telithromycin 800 mg once daily achieved clinical cure rates of 86 to 95%. "
01/01/2004 - "A pooled analysis of data from 13 phase III studies of telithromycin in the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute sinusitis or group A beta-haemolytic streptococcal pharyngitis and tonsillitis was undertaken. "
07/01/2003 - "In clinical trials, telithromycin has demonstrated high clinical and bacteriological efficacy in the treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute sinusitis and group A beta-haemolytic streptococcal tonsillitis/pharyngitis. "
02/01/2001 - "In clinical trials, telithromycin given orally at a dose of 800 mg once daily for 5 - 10 days was as effective as comparator antimicrobials for the treatment of adults with community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute maxillary sinusitis and group A-beta-haemolytic streptococcal pharyngitis or tonsillitis. "
Order ALL the reference details at left...

Therapies and Procedures

1. Tonsillectomy
2. Lasers (Laser)
3. Gas Lasers
4. Cardiopulmonary Resuscitation (CPR)
5. Homeopathy

Best Treatments:
Research Summary Report
on Tonsillitis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 78 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>